JBT Marel earnings date
Want to see JBTM full AI Analyst Report?
JBT Marel (JBTM) Q3 2026 Earnings Report
JBTM Q3 2026 EPS Results
- Actual EPS
- $2.19
- Consensus EPS
- $2.10
- Beat/Miss
- Beat by +$0.09
- One Year Ago EPS
- $1.94
JBTM Q3 2026 Revenue Results
- Actual Revenue
- $997.00M
- Expected Revenue
- $1.03B
- Beat/Miss
- Missed by -$33.63M
- YoY Revenue Growth
- -0.34%
Earnings Announcement Details
- Quarter
- Q3 2026
- Date
- 11/03/2026
- Time
- Before Open
- Conference Call
- Tuesday, November 3, 2026
JBT Marel's next earnings date is estimated for February 23, 2027, based on past reporting schedules.
Q3 2026 Earnings Call Audio
Q3 2026 Earnings Slide Deck
Q3 2026 Earnings Call Summary
The call was predominantly positive. Record adjusted EBITDA and margin, year-over-year EPS and Protein Solutions growth, strong cash flow, expanded buybacks, progress on integration and footprint rationalization, and favorable poultry demand outweighed the negative items. The principal challenges were the continued CPG downturn, a 1% consolidated revenue decline, the lower full-year revenue outlook, and tariff, logistics and supply-chain pressures.
For full year 2026, JBT Marel now expects revenue of $3.95 billion to $4 billion, representing year-over-year growth of approximately 5% at the midpoint, including a 1.5% foreign exchange benefit; adjusted EBITDA margin guidance is 17.25% to 17.5%, adjusted EPS guidance is $8.10 to $8.40, and fourth-quarter corporate expense is expected to be closer to $30 million. For the fourth quarter, management expects slightly higher growth in the Protein segment sequentially and slightly lower growth in Prepared Food and Beverage, more upward mobility on PFB margins sequentially and flatter margin progression on the protein side, with CPG expected to be flat at this lower level from Q3 to Q4 and short-term pressure to persist for at least the next quarter or 2. Management continues to support an adjusted EBITDA margin target of 20% in 2028, expects the footprint optimization to continue through the end of 2027, believes the business can return to mid-single-digit revenue growth, expects lower growth or flattish on the DF&H side, and is striving to reach mid-teen levels for Meat and Fish margins over the next 2 to 3 years.
- Record Adjusted EBITDA and MarginThird-quarter adjusted EBITDA reached a record $179 million, increasing 5% year-over-year, while adjusted EBITDA margin reached a record 18%.
- Improved Adjusted EPSAdjusted EPS grew 13% year-over-year, driven by better margins and lower interest expense.
- Protein Solutions GrowthProtein Solutions revenue increased 6% year-over-year, driven primarily by poultry volume. Segment margins improved 110 basis points, primarily from volume leverage, mix, pricing and cost synergy realization.
- Prepared Food and Beverage Margin ImprovementPrepared Food and Beverage Solutions margins improved 90 basis points year-over-year as improved Warehouse Automation performance, expense savings realization, mix and price discipline more than offset the margin impact of lower volume.
- Warehouse Automation RecoveryWarehouse Automation delivered meaningful cost improvements and revenue growth following its restructuring in the second quarter, contributing to improved performance within Prepared Food and Beverage Solutions.
- Strong Cash Flow and Capital ReturnsYear-to-date free cash flow was $252 million, an increase of approximately $90 million versus the prior year. Third-quarter free cash flow was $73 million, and the company repurchased 800,000 shares for $94 million while maintaining leverage below 2.5x.
- Expanded Share Repurchase AuthorizationThe Board increased the total share repurchase authorization to $700 million. Management said repurchases will primarily be opportunistic, while maintaining leverage targets between 2x and 2.5x and balancing buybacks with debt paydown.
- Raised Profitability and EPS GuidanceThe company increased adjusted EBITDA margin guidance to 17.25% to 17.5% and increased adjusted EPS guidance to $8.10 to $8.40, reflecting assumptions for lower interest expense, taxes and share count.
- Equipment Orders GrowthEquipment orders increased 3% year-over-year in the third quarter and 10% year-to-date. Diversified Food and Health had its best orders quarter since the JBT and Marel combination, supported by larger 2027 CPG projects.
- Strong Poultry Demand and BacklogManagement reported very strong momentum entering the fourth quarter for poultry globally across primary, secondary and further processing, along with a strong poultry backlog for fourth-quarter deliveries.
- U.S. Poultry Investment OpportunityManagement said U.S. primary and secondary poultry customers have underinvested relative to global standards and are engaged with JBT Marel on meaningful investments in automation and modernization. The company estimates approximately 250 to 275 U.S. poultry lines could be upgradable, with investments of approximately $3 million to $10 million per line over the next 5 years. A potential USDA ruling on higher line speeds could provide an additional multiyear tailwind.
- Footprint Rationalization ProgressJBT Marel completed the closure of 5 manufacturing, distribution and service facilities during the third quarter, including 1 large facility and 4 modest facilities, and has begun realizing the related run-rate benefits. Additional footprint optimization is planned through the end of 2027.
- Significant Margin Expansion Since Pre-Merger BaselineThe midpoint of 2026 adjusted EBITDA margin guidance implies more than 350 basis points of expansion versus the pre-merger baseline performance of the two companies in 2024. Management attributed the improvement to continuous improvement, supply chain optimization, labor efficiencies and initial footprint-consolidation benefits.
- Progress in Meat and Fish ProfitabilityThe Meat business improved from very low single-digit margins, close to 0%, at the time of the Marel combination to high single-digit margins. The Fish business improved from negative 5% to 10% EBITDA margins to a current range of 5% to 10%, with a stated goal of reaching mid-teen levels over the next 2 to 3 years.
- AGV Business RecoveryAGV had a strong third quarter after a difficult period from 2024 through the first half of 2026. Management said AGV improved from approximately a 0% EBITDA business to a very strong contributor in the third quarter and is beginning to rebuild backlog.
- Revenue Synergy ProgressJBT Marel achieved approximately $75 million of cumulative revenue synergy orders over the prior 12 months, reaching in 1.5 years a level originally targeted over 3 years. Management said interest in the integrated value proposition, particularly in Prepared Foods, secondary poultry and end-of-line solutions, has been stronger than initially expected.
- Customer Service and Digital InitiativesThe company is investing in its customer-first service organization, including AI tools to harmonize installed-base data with equipment maintenance cycles and provide share-of-wallet visibility. It is also piloting agentic workflows for quote assistance and more intelligent inventory tools to improve spare-parts fulfillment, lead times and parts availability.
- Integrated Food Technology StrategyJBT Marel is continuing to invest in core food technologies, full-line systems, software and digital tools, food application expertise, and service and aftermarket support as part of its integrated value proposition.
- Fourth-Quarter Seasonal and Backlog SupportManagement said fourth-quarter seasonality remains present, although it is not quite as accentuated as before the Marel combination. Expected support includes food-facility maintenance and installation activity after Thanksgiving shipments, higher-season orange juice lease activity in Brazil, and a strong poultry backlog.
JBTM Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 23, 2027 | 2026 (Q4) | 2.51- | 1.98 | ― | ― |
| Nov 03, 2026 | 2026 (Q3) | 2.102.19 | 1.94 | 12.89% (+0.25) | |
| Aug 03, 2026 | 2026 (Q2) | 2.021.95 | 1.49 | 30.87% (+0.46) | |
| May 04, 2026 | 2026 (Q1) | 1.481.58 | 0.97 | 62.89% (+0.61) | |
| Feb 23, 2026 | 2025 (Q4) | 1.901.98 | 1.7 | 16.47% (+0.28) | |
| Nov 03, 2025 | 2025 (Q3) | 1.501.94 | 1.5 | 29.33% (+0.44) | |
| Aug 04, 2025 | 2025 (Q2) | 1.281.49 | 1.05 | 41.90% (+0.44) | |
| May 05, 2025 | 2025 (Q1) | 0.840.97 | 0.85 | 14.12% (+0.12) | |
| Feb 24, 2025 | 2024 (Q4) | 1.811.70 | 1.4 | 21.43% (+0.30) | |
| Oct 22, 2024 | 2024 (Q3) | 1.411.50 | 1.11 | 35.14% (+0.39) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.


